nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—CYP2C19—prostate cancer	0.141	0.611	CbGaD
Pioglitazone—CYP3A4—prostate cancer	0.0898	0.389	CbGaD
Pioglitazone—SLCO1B3—Cabazitaxel—prostate cancer	0.0505	0.099	CbGbCtD
Pioglitazone—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0323	0.0633	CbGbCtD
Pioglitazone—SLCO1B1—Cabazitaxel—prostate cancer	0.0294	0.0577	CbGbCtD
Pioglitazone—SLCO1B1—Estrone—prostate cancer	0.0287	0.0564	CbGbCtD
Pioglitazone—SLCO1B3—Estradiol—prostate cancer	0.0283	0.0556	CbGbCtD
Pioglitazone—CYP2C8—Nilutamide—prostate cancer	0.0203	0.0398	CbGbCtD
Pioglitazone—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0188	0.0369	CbGbCtD
Pioglitazone—CYP2C19—Bicalutamide—prostate cancer	0.017	0.0334	CbGbCtD
Pioglitazone—CYP2C19—Nilutamide—prostate cancer	0.017	0.0334	CbGbCtD
Pioglitazone—SLCO1B3—Docetaxel—prostate cancer	0.0169	0.0332	CbGbCtD
Pioglitazone—CYP2C8—Abiraterone—prostate cancer	0.0168	0.033	CbGbCtD
Pioglitazone—SLCO1B1—Estradiol—prostate cancer	0.0165	0.0324	CbGbCtD
Pioglitazone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0157	0.0307	CbGbCtD
Pioglitazone—CYP2C9—Nilutamide—prostate cancer	0.0142	0.0278	CbGbCtD
Pioglitazone—CYP2C9—Bicalutamide—prostate cancer	0.0142	0.0278	CbGbCtD
Pioglitazone—CYP2C19—Flutamide—prostate cancer	0.0141	0.0277	CbGbCtD
Pioglitazone—CYP2D6—Bicalutamide—prostate cancer	0.0129	0.0254	CbGbCtD
Pioglitazone—CYP2C8—Cabazitaxel—prostate cancer	0.0124	0.0244	CbGbCtD
Pioglitazone—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0108	0.0213	CbGbCtD
Pioglitazone—CYP2D6—Abiraterone—prostate cancer	0.0107	0.021	CbGbCtD
Pioglitazone—CYP2C9—Estrone—prostate cancer	0.00848	0.0166	CbGbCtD
Pioglitazone—CYP3A4—Bicalutamide—prostate cancer	0.00823	0.0161	CbGbCtD
Pioglitazone—PTGS1—Etoposide—prostate cancer	0.0079	0.0155	CbGbCtD
Pioglitazone—CYP3A4—Estramustine—prostate cancer	0.00765	0.015	CbGbCtD
Pioglitazone—CYP2C8—Estradiol—prostate cancer	0.00698	0.0137	CbGbCtD
Pioglitazone—CYP3A4—Abiraterone—prostate cancer	0.00682	0.0134	CbGbCtD
Pioglitazone—CYP3A4—Flutamide—prostate cancer	0.00682	0.0134	CbGbCtD
Pioglitazone—CYP2C9—Capecitabine—prostate cancer	0.00643	0.0126	CbGbCtD
Pioglitazone—CYP2C19—Estradiol—prostate cancer	0.00586	0.0115	CbGbCtD
Pioglitazone—CYP3A4—Cabazitaxel—prostate cancer	0.00505	0.0099	CbGbCtD
Pioglitazone—CYP2C19—Prednisone—prostate cancer	0.00504	0.00988	CbGbCtD
Pioglitazone—CYP3A4—Estrone—prostate cancer	0.00493	0.00967	CbGbCtD
Pioglitazone—CYP2C9—Estradiol—prostate cancer	0.00487	0.00955	CbGbCtD
Pioglitazone—CYP2C8—Etoposide—prostate cancer	0.00456	0.00894	CbGbCtD
Pioglitazone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0044	0.00862	CbGbCtD
Pioglitazone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00323	0.00633	CbGbCtD
Pioglitazone—Rosiglitazone—ACSL4—prostate cancer	0.00299	0.778	CrCbGaD
Pioglitazone—CYP3A4—Mitoxantrone—prostate cancer	0.00293	0.00575	CbGbCtD
Pioglitazone—CYP3A4—Estradiol—prostate cancer	0.00283	0.00555	CbGbCtD
Pioglitazone—CYP3A4—Prednisone—prostate cancer	0.00244	0.00478	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—prostate cancer	0.00198	0.00389	CbGbCtD
Pioglitazone—CYP3A4—Etoposide—prostate cancer	0.00185	0.00363	CbGbCtD
Pioglitazone—CYP3A4—Docetaxel—prostate cancer	0.00169	0.00332	CbGbCtD
Pioglitazone—CYP2C19—urine—prostate cancer	0.00169	0.14	CbGeAlD
Pioglitazone—CYP2C9—urine—prostate cancer	0.00131	0.108	CbGeAlD
Pioglitazone—CYP3A4—Doxorubicin—prostate cancer	0.00126	0.00247	CbGbCtD
Pioglitazone—PPARG—Teniposide—Etoposide—prostate cancer	0.00124	1	CbGdCrCtD
Pioglitazone—CYP3A4—urine—prostate cancer	0.000997	0.0827	CbGeAlD
Pioglitazone—CYP2D6—urine—prostate cancer	0.000982	0.0814	CbGeAlD
Pioglitazone—PPARG—prostate gland—prostate cancer	0.000802	0.0665	CbGeAlD
Pioglitazone—SLCO1B1—renal system—prostate cancer	0.000634	0.0525	CbGeAlD
Pioglitazone—PPARG—epithelium—prostate cancer	0.000589	0.0489	CbGeAlD
Pioglitazone—PPARG—renal system—prostate cancer	0.000547	0.0453	CbGeAlD
Pioglitazone—PPARG—urethra—prostate cancer	0.000537	0.0445	CbGeAlD
Pioglitazone—Rosiglitazone—CYP2A6—prostate cancer	0.000503	0.131	CrCbGaD
Pioglitazone—PTGS1—prostate gland—prostate cancer	0.000429	0.0355	CbGeAlD
Pioglitazone—PPARG—bone marrow—prostate cancer	0.000413	0.0343	CbGeAlD
Pioglitazone—PTGS1—seminal vesicle—prostate cancer	0.000363	0.0301	CbGeAlD
Pioglitazone—CYP2C8—renal system—prostate cancer	0.00036	0.0299	CbGeAlD
Pioglitazone—Rosiglitazone—CYP2C19—prostate cancer	0.000354	0.0919	CrCbGaD
Pioglitazone—PPARG—testis—prostate cancer	0.000353	0.0293	CbGeAlD
Pioglitazone—PTGS1—epithelium—prostate cancer	0.000315	0.0261	CbGeAlD
Pioglitazone—PTGS1—renal system—prostate cancer	0.000292	0.0242	CbGeAlD
Pioglitazone—PPARG—lymph node—prostate cancer	0.000256	0.0212	CbGeAlD
Pioglitazone—CYP3A4—renal system—prostate cancer	0.000244	0.0202	CbGeAlD
Pioglitazone—CYP2D6—renal system—prostate cancer	0.00024	0.0199	CbGeAlD
Pioglitazone—CYP2C8—testis—prostate cancer	0.000233	0.0193	CbGeAlD
Pioglitazone—PTGS1—testis—prostate cancer	0.000189	0.0157	CbGeAlD
Pioglitazone—CYP2D6—testis—prostate cancer	0.000155	0.0129	CbGeAlD
Pioglitazone—PTGS1—lymph node—prostate cancer	0.000137	0.0114	CbGeAlD
Pioglitazone—Dizziness—Conjugated Estrogens—prostate cancer	6.08e-05	0.00041	CcSEcCtD
Pioglitazone—Feeling abnormal—Estradiol—prostate cancer	6.07e-05	0.000409	CcSEcCtD
Pioglitazone—Eye disorder—Capecitabine—prostate cancer	6.04e-05	0.000407	CcSEcCtD
Pioglitazone—Hypertension—Etoposide—prostate cancer	6.03e-05	0.000407	CcSEcCtD
Pioglitazone—Immune system disorder—Docetaxel—prostate cancer	6.03e-05	0.000406	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—prostate cancer	6.02e-05	0.000406	CcSEcCtD
Pioglitazone—Mediastinal disorder—Docetaxel—prostate cancer	6.01e-05	0.000405	CcSEcCtD
Pioglitazone—Liver function test abnormal—Epirubicin—prostate cancer	6.01e-05	0.000405	CcSEcCtD
Pioglitazone—Cardiac disorder—Capecitabine—prostate cancer	6e-05	0.000404	CcSEcCtD
Pioglitazone—Chest pain—Etoposide—prostate cancer	5.95e-05	0.000401	CcSEcCtD
Pioglitazone—Abdominal pain upper—Epirubicin—prostate cancer	5.94e-05	0.0004	CcSEcCtD
Pioglitazone—Fatigue—Mitoxantrone—prostate cancer	5.91e-05	0.000398	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	5.91e-05	0.000398	CcSEcCtD
Pioglitazone—Discomfort—Etoposide—prostate cancer	5.88e-05	0.000396	CcSEcCtD
Pioglitazone—Breast disorder—Epirubicin—prostate cancer	5.88e-05	0.000396	CcSEcCtD
Pioglitazone—Urticaria—Estradiol—prostate cancer	5.85e-05	0.000394	CcSEcCtD
Pioglitazone—Immune system disorder—Capecitabine—prostate cancer	5.84e-05	0.000393	CcSEcCtD
Pioglitazone—Mediastinal disorder—Capecitabine—prostate cancer	5.82e-05	0.000392	CcSEcCtD
Pioglitazone—Headache—Goserelin—prostate cancer	5.82e-05	0.000392	CcSEcCtD
Pioglitazone—Malnutrition—Docetaxel—prostate cancer	5.81e-05	0.000391	CcSEcCtD
Pioglitazone—Headache—Conjugated Estrogens—prostate cancer	5.76e-05	0.000388	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Epirubicin—prostate cancer	5.74e-05	0.000387	CcSEcCtD
Pioglitazone—Anaphylactic shock—Etoposide—prostate cancer	5.7e-05	0.000384	CcSEcCtD
Pioglitazone—Infection—Etoposide—prostate cancer	5.67e-05	0.000382	CcSEcCtD
Pioglitazone—Connective tissue disorder—Prednisone—prostate cancer	5.66e-05	0.000381	CcSEcCtD
Pioglitazone—Feeling abnormal—Mitoxantrone—prostate cancer	5.65e-05	0.000381	CcSEcCtD
Pioglitazone—Malnutrition—Capecitabine—prostate cancer	5.62e-05	0.000379	CcSEcCtD
Pioglitazone—Influenza—Epirubicin—prostate cancer	5.62e-05	0.000379	CcSEcCtD
Pioglitazone—Back pain—Docetaxel—prostate cancer	5.62e-05	0.000379	CcSEcCtD
Pioglitazone—Muscle spasms—Docetaxel—prostate cancer	5.58e-05	0.000376	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—prostate cancer	5.56e-05	0.000375	CcSEcCtD
Pioglitazone—Flatulence—Capecitabine—prostate cancer	5.54e-05	0.000373	CcSEcCtD
Pioglitazone—Skin disorder—Etoposide—prostate cancer	5.54e-05	0.000373	CcSEcCtD
Pioglitazone—Hyperhidrosis—Etoposide—prostate cancer	5.51e-05	0.000372	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—prostate cancer	5.5e-05	0.00037	CcSEcCtD
Pioglitazone—Angina pectoris—Epirubicin—prostate cancer	5.48e-05	0.000369	CcSEcCtD
Pioglitazone—Urticaria—Mitoxantrone—prostate cancer	5.45e-05	0.000367	CcSEcCtD
Pioglitazone—Back pain—Capecitabine—prostate cancer	5.44e-05	0.000367	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—prostate cancer	5.44e-05	0.000367	CcSEcCtD
Pioglitazone—Hypersensitivity—Estradiol—prostate cancer	5.42e-05	0.000365	CcSEcCtD
Pioglitazone—Bronchitis—Epirubicin—prostate cancer	5.41e-05	0.000364	CcSEcCtD
Pioglitazone—Muscle spasms—Capecitabine—prostate cancer	5.41e-05	0.000364	CcSEcCtD
Pioglitazone—Eye disorder—Prednisone—prostate cancer	5.38e-05	0.000362	CcSEcCtD
Pioglitazone—Anaemia—Docetaxel—prostate cancer	5.37e-05	0.000362	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—prostate cancer	5.31e-05	0.000358	CcSEcCtD
Pioglitazone—Asthenia—Estradiol—prostate cancer	5.28e-05	0.000356	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Epirubicin—prostate cancer	5.23e-05	0.000352	CcSEcCtD
Pioglitazone—Ill-defined disorder—Capecitabine—prostate cancer	5.22e-05	0.000352	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—prostate cancer	5.2e-05	0.000351	CcSEcCtD
Pioglitazone—Anaemia—Capecitabine—prostate cancer	5.2e-05	0.00035	CcSEcCtD
Pioglitazone—Immune system disorder—Prednisone—prostate cancer	5.2e-05	0.00035	CcSEcCtD
Pioglitazone—Weight increased—Epirubicin—prostate cancer	5.12e-05	0.000345	CcSEcCtD
Pioglitazone—Weight decreased—Epirubicin—prostate cancer	5.09e-05	0.000343	CcSEcCtD
Pioglitazone—Dyspnoea—Etoposide—prostate cancer	5.09e-05	0.000343	CcSEcCtD
Pioglitazone—Hyperglycaemia—Epirubicin—prostate cancer	5.07e-05	0.000342	CcSEcCtD
Pioglitazone—Malaise—Capecitabine—prostate cancer	5.07e-05	0.000342	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—prostate cancer	5.07e-05	0.000342	CcSEcCtD
Pioglitazone—Vertigo—Capecitabine—prostate cancer	5.05e-05	0.00034	CcSEcCtD
Pioglitazone—Hypersensitivity—Mitoxantrone—prostate cancer	5.05e-05	0.00034	CcSEcCtD
Pioglitazone—Diarrhoea—Estradiol—prostate cancer	5.04e-05	0.000339	CcSEcCtD
Pioglitazone—Hypertension—Docetaxel—prostate cancer	5.02e-05	0.000338	CcSEcCtD
Pioglitazone—Infestation NOS—Epirubicin—prostate cancer	5.01e-05	0.000338	CcSEcCtD
Pioglitazone—Infestation—Epirubicin—prostate cancer	5.01e-05	0.000338	CcSEcCtD
Pioglitazone—Malnutrition—Prednisone—prostate cancer	5.01e-05	0.000338	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—prostate cancer	5e-05	0.000337	CcSEcCtD
Pioglitazone—Arthralgia—Docetaxel—prostate cancer	4.95e-05	0.000333	CcSEcCtD
Pioglitazone—Chest pain—Docetaxel—prostate cancer	4.95e-05	0.000333	CcSEcCtD
Pioglitazone—Myalgia—Docetaxel—prostate cancer	4.95e-05	0.000333	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Etoposide—prostate cancer	4.92e-05	0.000332	CcSEcCtD
Pioglitazone—Asthenia—Mitoxantrone—prostate cancer	4.92e-05	0.000332	CcSEcCtD
Pioglitazone—Fatigue—Etoposide—prostate cancer	4.92e-05	0.000331	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	4.91e-05	0.000331	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—prostate cancer	4.87e-05	0.000328	CcSEcCtD
Pioglitazone—Dizziness—Estradiol—prostate cancer	4.87e-05	0.000328	CcSEcCtD
Pioglitazone—Hypertension—Capecitabine—prostate cancer	4.86e-05	0.000327	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—prostate cancer	4.84e-05	0.000326	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—prostate cancer	4.81e-05	0.000324	CcSEcCtD
Pioglitazone—Chest pain—Capecitabine—prostate cancer	4.79e-05	0.000323	CcSEcCtD
Pioglitazone—Arthralgia—Capecitabine—prostate cancer	4.79e-05	0.000323	CcSEcCtD
Pioglitazone—Myalgia—Capecitabine—prostate cancer	4.79e-05	0.000323	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—prostate cancer	4.78e-05	0.000322	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.76e-05	0.00032	CcSEcCtD
Pioglitazone—Anaphylactic shock—Docetaxel—prostate cancer	4.74e-05	0.000319	CcSEcCtD
Pioglitazone—Oedema—Docetaxel—prostate cancer	4.74e-05	0.000319	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—prostate cancer	4.73e-05	0.000319	CcSEcCtD
Pioglitazone—Discomfort—Capecitabine—prostate cancer	4.73e-05	0.000319	CcSEcCtD
Pioglitazone—Infection—Docetaxel—prostate cancer	4.71e-05	0.000317	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—prostate cancer	4.71e-05	0.000317	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—prostate cancer	4.7e-05	0.000317	CcSEcCtD
Pioglitazone—Feeling abnormal—Etoposide—prostate cancer	4.7e-05	0.000317	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—prostate cancer	4.69e-05	0.000316	CcSEcCtD
Pioglitazone—Diarrhoea—Mitoxantrone—prostate cancer	4.69e-05	0.000316	CcSEcCtD
Pioglitazone—Nervous system disorder—Docetaxel—prostate cancer	4.65e-05	0.000313	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisone—prostate cancer	4.65e-05	0.000313	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—prostate cancer	4.64e-05	0.000313	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—prostate cancer	4.64e-05	0.000313	CcSEcCtD
Pioglitazone—Anaemia—Prednisone—prostate cancer	4.63e-05	0.000312	CcSEcCtD
Pioglitazone—Headache—Estradiol—prostate cancer	4.61e-05	0.000311	CcSEcCtD
Pioglitazone—Skin disorder—Docetaxel—prostate cancer	4.6e-05	0.00031	CcSEcCtD
Pioglitazone—Oedema—Capecitabine—prostate cancer	4.59e-05	0.000309	CcSEcCtD
Pioglitazone—Angioedema—Prednisone—prostate cancer	4.58e-05	0.000308	CcSEcCtD
Pioglitazone—Infection—Capecitabine—prostate cancer	4.56e-05	0.000307	CcSEcCtD
Pioglitazone—Urticaria—Etoposide—prostate cancer	4.53e-05	0.000305	CcSEcCtD
Pioglitazone—Malaise—Prednisone—prostate cancer	4.52e-05	0.000304	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—prostate cancer	4.51e-05	0.000304	CcSEcCtD
Pioglitazone—Nervous system disorder—Capecitabine—prostate cancer	4.5e-05	0.000303	CcSEcCtD
Pioglitazone—Vertigo—Prednisone—prostate cancer	4.5e-05	0.000303	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—prostate cancer	4.5e-05	0.000303	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—prostate cancer	4.48e-05	0.000302	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—prostate cancer	4.47e-05	0.000301	CcSEcCtD
Pioglitazone—Skin disorder—Capecitabine—prostate cancer	4.46e-05	0.0003	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—prostate cancer	4.45e-05	0.0003	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—prostate cancer	4.44e-05	0.0003	CcSEcCtD
Pioglitazone—Hyperhidrosis—Capecitabine—prostate cancer	4.44e-05	0.000299	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—prostate cancer	4.43e-05	0.000299	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—prostate cancer	4.42e-05	0.000298	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—prostate cancer	4.42e-05	0.000298	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—prostate cancer	4.41e-05	0.000297	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—prostate cancer	4.35e-05	0.000293	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—prostate cancer	4.34e-05	0.000292	CcSEcCtD
Pioglitazone—Hypertension—Prednisone—prostate cancer	4.33e-05	0.000291	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.32e-05	0.000291	CcSEcCtD
Pioglitazone—Headache—Mitoxantrone—prostate cancer	4.3e-05	0.00029	CcSEcCtD
Pioglitazone—Insomnia—Docetaxel—prostate cancer	4.29e-05	0.000289	CcSEcCtD
Pioglitazone—Myalgia—Prednisone—prostate cancer	4.26e-05	0.000287	CcSEcCtD
Pioglitazone—Arthralgia—Prednisone—prostate cancer	4.26e-05	0.000287	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.24e-05	0.000285	CcSEcCtD
Pioglitazone—Dyspnoea—Docetaxel—prostate cancer	4.23e-05	0.000285	CcSEcCtD
Pioglitazone—Discomfort—Prednisone—prostate cancer	4.21e-05	0.000284	CcSEcCtD
Pioglitazone—Eye disorder—Epirubicin—prostate cancer	4.21e-05	0.000283	CcSEcCtD
Pioglitazone—Hypersensitivity—Etoposide—prostate cancer	4.2e-05	0.000283	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.18e-05	0.000282	CcSEcCtD
Pioglitazone—Cardiac disorder—Epirubicin—prostate cancer	4.18e-05	0.000281	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—prostate cancer	4.16e-05	0.000281	CcSEcCtD
Pioglitazone—Insomnia—Capecitabine—prostate cancer	4.15e-05	0.00028	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—prostate cancer	4.14e-05	0.000279	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—prostate cancer	4.13e-05	0.000279	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—prostate cancer	4.11e-05	0.000277	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—prostate cancer	4.1e-05	0.000276	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Docetaxel—prostate cancer	4.09e-05	0.000276	CcSEcCtD
Pioglitazone—Asthenia—Etoposide—prostate cancer	4.09e-05	0.000276	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—prostate cancer	4.09e-05	0.000276	CcSEcCtD
Pioglitazone—Dyspnoea—Capecitabine—prostate cancer	4.09e-05	0.000276	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisone—prostate cancer	4.09e-05	0.000276	CcSEcCtD
Pioglitazone—Oedema—Prednisone—prostate cancer	4.09e-05	0.000276	CcSEcCtD
Pioglitazone—Fatigue—Docetaxel—prostate cancer	4.09e-05	0.000275	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—prostate cancer	4.08e-05	0.000275	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—prostate cancer	4.07e-05	0.000274	CcSEcCtD
Pioglitazone—Infection—Prednisone—prostate cancer	4.06e-05	0.000274	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—prostate cancer	4.06e-05	0.000273	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—prostate cancer	4.01e-05	0.00027	CcSEcCtD
Pioglitazone—Nervous system disorder—Prednisone—prostate cancer	4.01e-05	0.00027	CcSEcCtD
Pioglitazone—Skin disorder—Prednisone—prostate cancer	3.97e-05	0.000268	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Capecitabine—prostate cancer	3.96e-05	0.000267	CcSEcCtD
Pioglitazone—Fatigue—Capecitabine—prostate cancer	3.96e-05	0.000267	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisone—prostate cancer	3.95e-05	0.000266	CcSEcCtD
Pioglitazone—Malnutrition—Epirubicin—prostate cancer	3.92e-05	0.000264	CcSEcCtD
Pioglitazone—Feeling abnormal—Docetaxel—prostate cancer	3.91e-05	0.000263	CcSEcCtD
Pioglitazone—Diarrhoea—Etoposide—prostate cancer	3.9e-05	0.000263	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—prostate cancer	3.89e-05	0.000262	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—prostate cancer	3.86e-05	0.00026	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—prostate cancer	3.86e-05	0.00026	CcSEcCtD
Pioglitazone—Back pain—Epirubicin—prostate cancer	3.79e-05	0.000255	CcSEcCtD
Pioglitazone—Feeling abnormal—Capecitabine—prostate cancer	3.78e-05	0.000255	CcSEcCtD
Pioglitazone—Dizziness—Etoposide—prostate cancer	3.77e-05	0.000254	CcSEcCtD
Pioglitazone—Muscle spasms—Epirubicin—prostate cancer	3.77e-05	0.000254	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—prostate cancer	3.76e-05	0.000253	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—prostate cancer	3.75e-05	0.000253	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Prednisone—prostate cancer	3.72e-05	0.000251	CcSEcCtD
Pioglitazone—Insomnia—Prednisone—prostate cancer	3.7e-05	0.000249	CcSEcCtD
Pioglitazone—Urticaria—Capecitabine—prostate cancer	3.65e-05	0.000246	CcSEcCtD
Pioglitazone—Ill-defined disorder—Epirubicin—prostate cancer	3.64e-05	0.000245	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—prostate cancer	3.63e-05	0.000244	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—prostate cancer	3.62e-05	0.000244	CcSEcCtD
Pioglitazone—Headache—Etoposide—prostate cancer	3.57e-05	0.000241	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—prostate cancer	3.57e-05	0.000241	CcSEcCtD
Pioglitazone—Malaise—Epirubicin—prostate cancer	3.53e-05	0.000238	CcSEcCtD
Pioglitazone—Fatigue—Prednisone—prostate cancer	3.52e-05	0.000238	CcSEcCtD
Pioglitazone—Vertigo—Epirubicin—prostate cancer	3.52e-05	0.000237	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—prostate cancer	3.51e-05	0.000236	CcSEcCtD
Pioglitazone—Hypersensitivity—Docetaxel—prostate cancer	3.49e-05	0.000235	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—prostate cancer	3.49e-05	0.000235	CcSEcCtD
Pioglitazone—Asthenia—Docetaxel—prostate cancer	3.4e-05	0.000229	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—prostate cancer	3.38e-05	0.000228	CcSEcCtD
Pioglitazone—Hypersensitivity—Capecitabine—prostate cancer	3.38e-05	0.000228	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisone—prostate cancer	3.37e-05	0.000227	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—prostate cancer	3.36e-05	0.000227	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—prostate cancer	3.35e-05	0.000226	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—prostate cancer	3.34e-05	0.000225	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—prostate cancer	3.34e-05	0.000225	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—prostate cancer	3.34e-05	0.000225	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.31e-05	0.000223	CcSEcCtD
Pioglitazone—Discomfort—Epirubicin—prostate cancer	3.3e-05	0.000222	CcSEcCtD
Pioglitazone—Asthenia—Capecitabine—prostate cancer	3.29e-05	0.000222	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—prostate cancer	3.27e-05	0.00022	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—prostate cancer	3.26e-05	0.000219	CcSEcCtD
Pioglitazone—Urticaria—Prednisone—prostate cancer	3.25e-05	0.000219	CcSEcCtD
Pioglitazone—Diarrhoea—Docetaxel—prostate cancer	3.24e-05	0.000219	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—prostate cancer	3.2e-05	0.000215	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—prostate cancer	3.2e-05	0.000215	CcSEcCtD
Pioglitazone—Infection—Epirubicin—prostate cancer	3.18e-05	0.000214	CcSEcCtD
Pioglitazone—Diarrhoea—Capecitabine—prostate cancer	3.14e-05	0.000212	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—prostate cancer	3.14e-05	0.000211	CcSEcCtD
Pioglitazone—Dizziness—Docetaxel—prostate cancer	3.13e-05	0.000211	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—prostate cancer	3.13e-05	0.000211	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—prostate cancer	3.11e-05	0.000209	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—prostate cancer	3.09e-05	0.000208	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—prostate cancer	3.09e-05	0.000208	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—prostate cancer	3.09e-05	0.000208	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—prostate cancer	3.09e-05	0.000208	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.07e-05	0.000207	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—prostate cancer	3.05e-05	0.000205	CcSEcCtD
Pioglitazone—Dizziness—Capecitabine—prostate cancer	3.04e-05	0.000205	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisone—prostate cancer	3.01e-05	0.000203	CcSEcCtD
Pioglitazone—Headache—Docetaxel—prostate cancer	2.97e-05	0.0002	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—prostate cancer	2.96e-05	0.000199	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—prostate cancer	2.96e-05	0.000199	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—prostate cancer	2.94e-05	0.000198	CcSEcCtD
Pioglitazone—Asthenia—Prednisone—prostate cancer	2.93e-05	0.000198	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.91e-05	0.000196	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—prostate cancer	2.9e-05	0.000196	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—prostate cancer	2.89e-05	0.000195	CcSEcCtD
Pioglitazone—Headache—Capecitabine—prostate cancer	2.88e-05	0.000194	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—prostate cancer	2.87e-05	0.000194	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—prostate cancer	2.86e-05	0.000193	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—prostate cancer	2.85e-05	0.000192	CcSEcCtD
Pioglitazone—Diarrhoea—Prednisone—prostate cancer	2.8e-05	0.000189	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Epirubicin—prostate cancer	2.76e-05	0.000186	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—prostate cancer	2.76e-05	0.000186	CcSEcCtD
Pioglitazone—Dizziness—Prednisone—prostate cancer	2.7e-05	0.000182	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.7e-05	0.000182	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—prostate cancer	2.68e-05	0.00018	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—prostate cancer	2.64e-05	0.000178	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—prostate cancer	2.64e-05	0.000178	CcSEcCtD
Pioglitazone—Headache—Prednisone—prostate cancer	2.56e-05	0.000173	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.55e-05	0.000172	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—prostate cancer	2.55e-05	0.000172	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—prostate cancer	2.54e-05	0.000171	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—prostate cancer	2.44e-05	0.000164	CcSEcCtD
Pioglitazone—Hypersensitivity—Epirubicin—prostate cancer	2.36e-05	0.000159	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—prostate cancer	2.35e-05	0.000158	CcSEcCtD
Pioglitazone—Asthenia—Epirubicin—prostate cancer	2.29e-05	0.000155	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—prostate cancer	2.19e-05	0.000147	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—prostate cancer	2.18e-05	0.000147	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—prostate cancer	2.12e-05	0.000143	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—prostate cancer	2.11e-05	0.000142	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—prostate cancer	2.02e-05	0.000136	CcSEcCtD
Pioglitazone—Headache—Epirubicin—prostate cancer	2e-05	0.000135	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—prostate cancer	1.96e-05	0.000132	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—prostate cancer	1.85e-05	0.000125	CcSEcCtD
Pioglitazone—CYP3A4—Metabolism—GSTA3—prostate cancer	3.3e-06	3.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ACHE—prostate cancer	3.3e-06	3.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTT1—prostate cancer	3.3e-06	3.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.3e-06	3.52e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP2A6—prostate cancer	3.29e-06	3.51e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—prostate cancer	3.29e-06	3.51e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP3A4—prostate cancer	3.28e-06	3.51e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.27e-06	3.49e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NCOA2—prostate cancer	3.26e-06	3.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP2A6—prostate cancer	3.26e-06	3.48e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CAV1—prostate cancer	3.26e-06	3.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.25e-06	3.47e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CB—prostate cancer	3.25e-06	3.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1B1—prostate cancer	3.23e-06	3.45e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—prostate cancer	3.22e-06	3.43e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKR1C3—prostate cancer	3.2e-06	3.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PRKACB—prostate cancer	3.18e-06	3.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.17e-06	3.38e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—INS—prostate cancer	3.16e-06	3.37e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PRKACB—prostate cancer	3.15e-06	3.37e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP17A1—prostate cancer	3.15e-06	3.36e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.15e-06	3.36e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.15e-06	3.36e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—EP300—prostate cancer	3.13e-06	3.35e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GGT1—prostate cancer	3.13e-06	3.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.12e-06	3.33e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC5A5—prostate cancer	3.11e-06	3.32e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.11e-06	3.32e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CREBBP—prostate cancer	3.09e-06	3.3e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NCOA1—prostate cancer	3.08e-06	3.29e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.08e-06	3.29e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP2E1—prostate cancer	3.04e-06	3.24e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP19A1—prostate cancer	3.04e-06	3.24e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA4—prostate cancer	3.02e-06	3.22e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.02e-06	3.22e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NQO1—prostate cancer	3.01e-06	3.21e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NCOA2—prostate cancer	3e-06	3.2e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—prostate cancer	3e-06	3.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NCOA2—prostate cancer	2.97e-06	3.18e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CG—prostate cancer	2.97e-06	3.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TH—prostate cancer	2.96e-06	3.16e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.94e-06	3.14e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA2—prostate cancer	2.94e-06	3.14e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CD—prostate cancer	2.93e-06	3.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP3A4—prostate cancer	2.93e-06	3.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—RXRA—prostate cancer	2.93e-06	3.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.92e-06	3.11e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.9e-06	3.1e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCG5—prostate cancer	2.9e-06	3.1e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.88e-06	3.08e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.86e-06	3.06e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.85e-06	3.04e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.84e-06	3.03e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTA1—prostate cancer	2.84e-06	3.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—COMT—prostate cancer	2.82e-06	3.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTP1—prostate cancer	2.81e-06	3e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—INS—prostate cancer	2.81e-06	3e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.81e-06	2.99e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTO1—prostate cancer	2.81e-06	2.99e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NAT2—prostate cancer	2.81e-06	2.99e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—prostate cancer	2.8e-06	2.99e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.8e-06	2.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GGT1—prostate cancer	2.79e-06	2.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.77e-06	2.96e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NOS3—prostate cancer	2.77e-06	2.96e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NQO1—prostate cancer	2.76e-06	2.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ITPR1—prostate cancer	2.76e-06	2.95e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CREBBP—prostate cancer	2.75e-06	2.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NCOA1—prostate cancer	2.75e-06	2.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NQO1—prostate cancer	2.74e-06	2.93e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TH—prostate cancer	2.72e-06	2.91e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.72e-06	2.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.71e-06	2.89e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TH—prostate cancer	2.7e-06	2.88e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.7e-06	2.88e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LRP2—prostate cancer	2.69e-06	2.87e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.69e-06	2.87e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PLCB2—prostate cancer	2.69e-06	2.87e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.68e-06	2.86e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—EP300—prostate cancer	2.67e-06	2.85e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.67e-06	2.85e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.66e-06	2.84e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.65e-06	2.83e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—P4HB—prostate cancer	2.64e-06	2.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.63e-06	2.8e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—RXRA—prostate cancer	2.61e-06	2.79e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TYMS—prostate cancer	2.61e-06	2.79e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CD—prostate cancer	2.61e-06	2.78e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—prostate cancer	2.58e-06	2.76e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GGT1—prostate cancer	2.57e-06	2.74e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.57e-06	2.74e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CB—prostate cancer	2.56e-06	2.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GGT1—prostate cancer	2.54e-06	2.72e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.54e-06	2.71e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—LPL—prostate cancer	2.53e-06	2.7e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—prostate cancer	2.53e-06	2.7e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NCOA1—prostate cancer	2.53e-06	2.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—COMT—prostate cancer	2.52e-06	2.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTP1—prostate cancer	2.51e-06	2.68e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NCOA1—prostate cancer	2.51e-06	2.68e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.5e-06	2.67e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.49e-06	2.66e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.47e-06	2.64e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ITPR1—prostate cancer	2.47e-06	2.63e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NOS3—prostate cancer	2.46e-06	2.63e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MED12—prostate cancer	2.46e-06	2.63e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.45e-06	2.61e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GNG5—prostate cancer	2.44e-06	2.6e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ERCC2—prostate cancer	2.43e-06	2.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.43e-06	2.59e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—RXRA—prostate cancer	2.41e-06	2.57e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—RXRA—prostate cancer	2.38e-06	2.55e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOA3—prostate cancer	2.35e-06	2.51e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TYMS—prostate cancer	2.33e-06	2.49e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.32e-06	2.48e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—prostate cancer	2.32e-06	2.48e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—COMT—prostate cancer	2.32e-06	2.47e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTP1—prostate cancer	2.31e-06	2.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—prostate cancer	2.3e-06	2.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—COMT—prostate cancer	2.3e-06	2.45e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTP1—prostate cancer	2.29e-06	2.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTHFR—prostate cancer	2.28e-06	2.43e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CB—prostate cancer	2.27e-06	2.43e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ITPR1—prostate cancer	2.27e-06	2.42e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—LPL—prostate cancer	2.26e-06	2.41e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—prostate cancer	2.25e-06	2.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ITPR1—prostate cancer	2.25e-06	2.4e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HPGDS—prostate cancer	2.24e-06	2.39e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARA—prostate cancer	2.24e-06	2.39e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.23e-06	2.38e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.21e-06	2.36e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—prostate cancer	2.21e-06	2.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.18e-06	2.33e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTT1—prostate cancer	2.18e-06	2.32e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ACHE—prostate cancer	2.18e-06	2.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ERCC2—prostate cancer	2.17e-06	2.31e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.15e-06	2.29e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TYMS—prostate cancer	2.14e-06	2.29e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TYMS—prostate cancer	2.13e-06	2.27e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—prostate cancer	2.12e-06	2.26e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—EP300—prostate cancer	2.11e-06	2.25e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CAV1—prostate cancer	2.1e-06	2.25e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—prostate cancer	2.1e-06	2.24e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.09e-06	2.23e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PRKACB—prostate cancer	2.08e-06	2.22e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—LPL—prostate cancer	2.08e-06	2.22e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—prostate cancer	2.08e-06	2.22e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—LPL—prostate cancer	2.06e-06	2.2e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.06e-06	2.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTHFR—prostate cancer	2.04e-06	2.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.01e-06	2.15e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.01e-06	2.14e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARA—prostate cancer	2e-06	2.13e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ERCC2—prostate cancer	1.99e-06	2.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.99e-06	2.13e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—prostate cancer	1.98e-06	2.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ERCC2—prostate cancer	1.98e-06	2.11e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—prostate cancer	1.96e-06	2.1e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.96e-06	2.09e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.92e-06	2.05e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—prostate cancer	1.89e-06	2.02e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CAV1—prostate cancer	1.88e-06	2e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—EP300—prostate cancer	1.87e-06	2e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTHFR—prostate cancer	1.87e-06	2e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.87e-06	2e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTHFR—prostate cancer	1.86e-06	1.98e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARA—prostate cancer	1.84e-06	1.96e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.83e-06	1.95e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARA—prostate cancer	1.82e-06	1.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—INS—prostate cancer	1.81e-06	1.94e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NQO1—prostate cancer	1.81e-06	1.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.79e-06	1.92e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TH—prostate cancer	1.78e-06	1.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CREBBP—prostate cancer	1.78e-06	1.9e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.73e-06	1.85e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CAV1—prostate cancer	1.73e-06	1.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CAV1—prostate cancer	1.71e-06	1.83e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.71e-06	1.83e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.68e-06	1.8e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GGT1—prostate cancer	1.68e-06	1.79e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.65e-06	1.76e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.64e-06	1.75e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.63e-06	1.74e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—INS—prostate cancer	1.62e-06	1.73e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—prostate cancer	1.62e-06	1.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NOS3—prostate cancer	1.59e-06	1.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CREBBP—prostate cancer	1.59e-06	1.69e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.57e-06	1.68e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—RXRA—prostate cancer	1.57e-06	1.68e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.56e-06	1.66e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.56e-06	1.66e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—COMT—prostate cancer	1.51e-06	1.62e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.51e-06	1.61e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.5e-06	1.61e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—INS—prostate cancer	1.49e-06	1.59e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.48e-06	1.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—INS—prostate cancer	1.48e-06	1.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.47e-06	1.57e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CREBBP—prostate cancer	1.46e-06	1.56e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—prostate cancer	1.46e-06	1.55e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CREBBP—prostate cancer	1.45e-06	1.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NOS3—prostate cancer	1.42e-06	1.52e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TYMS—prostate cancer	1.4e-06	1.5e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—prostate cancer	1.39e-06	1.48e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.39e-06	1.48e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.38e-06	1.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.37e-06	1.46e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—LPL—prostate cancer	1.36e-06	1.45e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.31e-06	1.4e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.31e-06	1.4e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NOS3—prostate cancer	1.31e-06	1.39e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.3e-06	1.39e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—prostate cancer	1.3e-06	1.39e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NOS3—prostate cancer	1.29e-06	1.38e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—prostate cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—prostate cancer	1.27e-06	1.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.22e-06	1.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—EP300—prostate cancer	1.21e-06	1.29e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.21e-06	1.29e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARA—prostate cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—prostate cancer	1.19e-06	1.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—prostate cancer	1.18e-06	1.26e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—prostate cancer	1.13e-06	1.21e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—prostate cancer	1.13e-06	1.21e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CAV1—prostate cancer	1.13e-06	1.21e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—EP300—prostate cancer	1.08e-06	1.15e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—prostate cancer	1.04e-06	1.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—prostate cancer	1.03e-06	1.1e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.03e-06	1.1e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—EP300—prostate cancer	9.94e-07	1.06e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—EP300—prostate cancer	9.85e-07	1.05e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—INS—prostate cancer	9.74e-07	1.04e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CREBBP—prostate cancer	9.54e-07	1.02e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.04e-07	9.65e-06	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—prostate cancer	8.95e-07	9.56e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NOS3—prostate cancer	8.54e-07	9.11e-06	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—prostate cancer	7.99e-07	8.53e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.88e-07	8.41e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—prostate cancer	7.81e-07	8.34e-06	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.35e-07	7.84e-06	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—prostate cancer	7.31e-07	7.81e-06	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.29e-07	7.78e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—prostate cancer	6.81e-07	7.27e-06	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—prostate cancer	6.53e-07	6.97e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—EP300—prostate cancer	6.5e-07	6.93e-06	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—prostate cancer	6e-07	6.41e-06	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—prostate cancer	5.95e-07	6.35e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.81e-07	5.13e-06	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—prostate cancer	3.93e-07	4.19e-06	CbGpPWpGaD
